GovContracts · GovTest · GovIT · GovLab · GovMedical
The new laboratory has been five years in the making. It replaces the old laboratory which is more than 30 years old and built in the basement of a building. The new facility is 18,000 square feet, and it cost a total of $7 million.
The facility offers access to labs, affordable rent, common areas like conference rooms and most important of all a network among each other, the state’s pharmaceutical industry and 15 research universities in New Jersey and nationwide.
The Department of Defense, in particular, can be a fruitful source of grant funding for biomedical firms in industry sectors such as telemedicine, infectious disease, chemical defense and environmental medicine.
Brookhaven Lab will take part in a pioneering effort to make its research facilities and expertise more readily available to private companies trying to move newly developed technologies from the drawing board to the marketplace.
The technology opens the possibility of screening for several hundred biomarkers in a single assay, in a very high-throughput and quantitative fashion.
The flexibility of the Infinite M1000 has enabled scientists to develop a simple and cost-effective automated screening method based on fluorescent or luminescent reporter detection in live zebrafish.
The settlement resolves a False Claims Act lawsuit that alleges Oracle intentionally gave GSA inaccurate information about discounts it gave to commercial customers and failed to pass those discounts on to the government.
Ultra-fast full spectrum analysis, multimode shaking, incubation, kinetic readings, well scanning, automated path length correction a gas vent and robotic friendly are only a few of the outstanding features that BMG LABTECH ’s SPECTROstar Nano has to offer.
Dramatic improvements can and must be made to the now mostly manual sample preparation procedures that have become THE lab bottleneck.
A number of House Representatives and U.S. Senators, stakeholders, and policymakers have begun to focus their efforts on ways to bring innovation in medical and scientific research back to the forefront of American health care policy.
